ORKA
Oruka Therapeutics, Inc.
79.50$
-0.8%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 99.3% | 99.3% | 99.9% | 99.9% | 99.7% | 95.2% | 93.4% | 92.9% | 69.7% | 70.4% | 78.3% | 77.6% | |
| 98.2% | 98.9% | 97.8% | 98.3% | 99.2% | 15.5% | 22.2% | 18.3% | 17.9% | 9.6% | 9.8% | 23.6% | |
| 98.2% | 98.9% | 97.8% | 98.3% | 99.2% | 94.9% | 92.6% | 91.9% | 68.6% | 69.0% | 77.1% | 76.7% | |
| 3.1% | 2.2% | 4.3% | 3.8% | 17.3% | 3.5% | 3.3% | 3.9% | 4.4% | 3.4% | 3.5% | 2.2% | |
| 2.5% | 1.7% | 4.3% | 3.8% | 4.4% | 3.3% | 3.1% | 3.4% | 4.1% | 3.1% | 3.3% | 2.0% | |
| 0.2% | 0.2% | 0.1% | 0.1% | 0.0% | 0.1% | 0.1% | 0.2% | 0.1% | 0.1% | 0.1% | 0.1% | |
| – | – | 1.4% | 1.7% | 2.1% | 0.9% | 0.9% | 1.3% | 0.4% | 0.9% | 0.7% | 0.7% | |
| – | – | 68.1% | – | – | – | – | – | – | – | – | – | |
| 96.9% | 97.8% | 95.7% | 96.2% | 82.7% | 96.5% | 96.7% | 96.1% | 95.6% | 96.6% | 96.5% | 97.8% | |
| -478.9% | -498.5% | -519.7% | -571.5% | -14.0% | -21.1% | -27.8% | -36.2% | -31.3% | -38.7% | -43.8% | -23.0% | |
| 36.8% | 38.1% | 39.5% | 42.9% | 3.6% | 4.2% | 11.1% | 11.8% | 8.7% | 11.1% | 10.9% | 5.5% |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.